Literature DB >> 9138006

Effects of IL-13 on murine listeriosis.

I E Flesch1, A Wandersee, S H Kaufmann.   

Abstract

Acquired resistance against Listeria monocytogenes is a typical T helper (Th) 1 dominated immune response, whereas Th2 cytokines are thought to worsen listeriosis. We investigated effects of recombinant IL-13 (rIL-13) on the host response to L. monocytogenes in mice. Although IL-13 has been described as a Th2 cytokine with deactivating anti-inflammatory activities, it was found to enhance antilisterial resistance. In vitro, rIL-13 increased IL-12 p40 and p70 production by bone marrow macrophages infected with L. monocytogenes. In vivo, numbers of viable bacteria in spleens and livers were decreased after treatment of mice with rIL-13. In addition, granuloma formation was impaired and NK cell activity of spleen cells was enhanced. At the onset of infection, frequencies of IL-12-producing cells were increased and numbers of IL-4- and IFN-gamma-secreting cells were diminished in rIL-13-treated mice as compared to controls. In contrast, on day 6 after infection, IL-12, IL-4 and IFN-gamma levels in rIL-13-treated animals were equal to or even higher than those in controls. Although direct activation of host macrophages by IL-13 is possible, we consider it more likely that IL-13 acted indirectly through stimulation of IL-12 production and inhibition of IL-4 release early after infection. In contrast, our data argue against an apparent role of IFN-gamma in IL-13-induced antilisterial resistance.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9138006     DOI: 10.1093/intimm/9.4.467

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  7 in total

1.  IL-18 stimulates IL-13-mediated IFN-gamma-sensitive host resistance in vivo.

Authors:  Qian Liu; Zhugong Liu; Jeannette Whitmire; Farhang Alem; Hossein Hamed; John Pesce; Joseph F Urban; William C Gause
Journal:  Eur J Immunol       Date:  2006-05       Impact factor: 5.532

2.  Aeroallergens Exacerbate Histoplasma capsulatum Infection.

Authors:  Chelsea L Bueter; George S Deepe
Journal:  J Immunol       Date:  2018-10-22       Impact factor: 5.422

3.  Endogenous IL-13 plays a crucial role in liver granuloma maturation during Leishmania donovani infection, independent of IL-4Rα-responsive macrophages and neutrophils.

Authors:  Emma McFarlane; Katharine C Carter; Andrew N McKenzie; Paul M Kaye; Frank Brombacher; James Alexander
Journal:  J Infect Dis       Date:  2011-07-01       Impact factor: 5.226

4.  Perinatal Immunization With Vaccine-Grade Listeria monocytogenes Provides Protection Against Murine Th2 Airway Inflammation.

Authors:  Sheka Yagub Aloyouni; Charis-Patricia Segeritz; Ashley M Sherrid; Matthew J Gold; Daniela I M Loeffler; Marie-Renée Blanchet; Bing Cai; Jeremy Hirota; Kelly M McNagny; Tobias R Kollmann
Journal:  Allergy Asthma Immunol Res       Date:  2014-03-21       Impact factor: 5.764

5.  Evaluation of two different vaccine platforms for immunization against melioidosis and glanders.

Authors:  Sergei S Biryukov; Christopher K Cote; Christopher P Klimko; Jennifer L Dankmeyer; Nathaniel O Rill; Jennifer L Shoe; Melissa Hunter; Zain Shamsuddin; Ivan Velez; Zander M Hedrick; Raysa Rosario-Acevedo; Yuli Talyansky; Lindsey K Schmidt; Caitlyn E Orne; David P Fetterer; Mary N Burtnick; Paul J Brett; Susan L Welkos; David DeShazer
Journal:  Front Microbiol       Date:  2022-08-17       Impact factor: 6.064

6.  Deletion of IL-4Ralpha on CD4 T cells renders BALB/c mice resistant to Leishmania major infection.

Authors:  Magdalena Radwanska; Antony J Cutler; J Claire Hoving; Stefan Magez; Christoph Holscher; Andreas Bohms; Berenice Arendse; Richard Kirsch; Thomas Hunig; James Alexander; Paul Kaye; Frank Brombacher
Journal:  PLoS Pathog       Date:  2007-05-11       Impact factor: 6.823

7.  IL-4 receptor-alpha-dependent control of Cryptococcus neoformans in the early phase of pulmonary infection.

Authors:  Andreas Grahnert; Tina Richter; Daniel Piehler; Maria Eschke; Bianca Schulze; Uwe Müller; Martina Protschka; Gabriele Köhler; Robert Sabat; Frank Brombacher; Gottfried Alber
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.